FdaApplication
BLA 761126
Identifiers
- fda_app_no: BLA761126
Properties
| Property | Value |
|---|---|
| applicant_name | Tanvex BioPharma USA, Inc. |
| application_type | BLA |
| approval_date | 2024-06-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NYPOZI | FILGRASTIM-TXID | 480MCG/0.8ML | Injection |
| NYPOZI | FILGRASTIM-TXID | 300MCG/0.5ML | Injection |
2 products